Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 943 of 5804
-
Summer camp therapy aims to boost movement in kids with cerebral palsy
Symptom relief Not yet recruitingThis interventional study will evaluate the effects of an intensive HABIT-ILE-based camp on cardiorespiratory measures and body composition in children with cerebral palsy. Although intensive motor control-based therapies such as HABIT/HABIT-ILE have shown functional benefits, th…
Phase: NA • Sponsor: Universidad Europea de Madrid • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThe goal of this study is to further evaluate feasibility and tolerability of Opdualag for patients with replication repair deficient HGG, including DIPG.
Phase: PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill could help asthma sufferers breathe easier
Disease control Not yet recruitingThis study explores a potential new treatment for adults with moderate-to-severe asthma using a drug called linvemastat, which targets an enzyme linked to lung inflammation. Despite using standard asthma medications, many patients still struggle with symptoms, so researchers are …
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Smart monitor could spot fetal distress before It's too late
Knowledge-focused Not yet recruitingPerinatal asphyxia affects 3 to 8 newborns per 1,000 births, with moderate or severe anoxic-ischemic encephalopathy occurring in 0.5 to 1 per 1,000 births. Approximately 15 to 20% of affected newborns will die during the postnatal period, and 25 to 50% of those who survive will d…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Could a common painkiller boost the Morning-After pill?
Disease control Not yet recruitingThis randomized controlled trial will test oral levonorgestrel + piroxicam vs. levonorgestrel + placebo for emergency contraception in a representative U.S. population that has higher pregnancy risk than in the prior study because of higher weights, different intercourse patterns…
Phase: PHASE3 • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for kids with ITP: drug combo aims to control bleeding
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy, safety and pharmacokinetics (PK) of ianalumab (VAY736) in addition to eltrombopag treatment; and to inform the dose of ianalumab in pediatric patients (5 to \<18 years of age) with primary ITP who have had an insufficient respo…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New program aims to curb suicide risk in teens on probation
Knowledge-focused Not yet recruitingThe goal of this study is to conduct a pilot test of a mental health support program called the Youth-Nominated Support Team - Probation (YST-P) for young people ages 12-17 on probation, experiencing suicidal ideation and behaviors (SIB). Young people on probation experience SIB …
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Could your own fat cells protect your new liver?
Disease control Not yet recruitingThe purpose of this study is to assess the safety of autologous Adipose-Derived Mesenchymal Stem Cell for use in End-Stage Liver Disease patients undergoing the creation of a duct-to-duct anastomosis during Living Donor Liver Transplantation.
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill could regrow hair in balding men
Disease control Not yet recruitingThis study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of N1087 compared with placebo in adult men with androgenetic alopecia (male pattern hair loss). The study will include male participants aged 18 to 60 years who have a clinical diagnosis of andr…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Virtual nature walks may ease pain and fear during needle procedures
Symptom relief Not yet recruitingMedical and technological advancements allow increasingly complex invasive procedures to be performed on hospitalized patients, improving their survival rates and prognosis. However, these interventions impact physical, emotional, and psychological health. In this scenario, post-…
Phase: NA • Sponsor: diana garcia • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Can a chatbot and peer groups help youth with HIV stay healthy?
Disease control Not yet recruitingYouth living with HIV (YLWH) experience mental health (MH) challenges that compromise their HIV care. Though the MH gap is well described, MH service delivery to YLWH is rare, especially in low resource settings. MH professionals are few and interventions tailored to the needs of…
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New weekly shot could help asian adults shed pounds
Disease control Not yet recruitingThe purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get zenagamtide (the treatme…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Blood filter aims to calm deadly inflammation in septic shock
Disease control Not yet recruitingSeptic shock is the most severe form of sepsis and continues to carry an in-hospital mortality of between 30% and 50% despite advances in compliance with the Surviving Sepsis Campaign care bundles. The pathophysiology of septic shock is dominated by an uncontrolled immuno-inflam…
Phase: NA • Sponsor: Miguel Sanchez Garcia • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a monthly pill replace painful penicillin shots for rheumatic heart disease?
Disease control Not yet recruitingBackground: Nigeria, among other Low and Middle-income countries, bears one of the highest burdens of RHD in Africa, affecting young to middle-aged adults within their productive years. This leads to loss of productivity, high out-of-pocket costs, and increased mortality risk. Ch…
Phase: NA • Sponsor: Ladoke Akintola University of Technology, Ogbomoso, Nigeria • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Bladder-bowel relief without pills: physiotherapy and exercise put to the test in teens with obesity
Symptom relief Not yet recruitingBladder and bowel dysfunction (BBD) is a common condition that includes problems such as urinary urgency, daytime urinary incontinence, bedwetting, constipation, or difficulties emptying the bladder or bowel. These symptoms can negatively affect quality of life, emotional well-be…
Phase: NA • Sponsor: University of Lisbon • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can a seizure drug tame autism irritability? new trial aims to find out
Symptom relief Not yet recruitingThe goal of this study is to conduct a randomized, placebo-controlled trial (RCT) of ganaxolone, a neuroactive steroid (NAS), in autistic children and adolescents aged 5 to 17 years old. Ganaxolone is approved and effective for treating seizures in children as young as 2 years ol…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Robotic surgery breakthrough aims to slash chest pain after esophageal cancer surgery
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate the feasibility and safety of a novel non-intercostal robotic approach for minimally invasive esophagectomy (OTC MIE) in the treatment of esophageal cancer. This study aims to determine whether OTC MIE reduces the risk of acute and c…
Phase: PHASE1 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Tiny blood vessels hold clues to heart surgery outcomes
Knowledge-focused TerminatedThe hypothesis under the study is that there could be a link between a dysfunction in peripheral microcirculation, sublingual microcirculation or cardiovascular control and the development of post cardiac surgery major morbidities (stroke, acute kidney injury, prolonged intubatio…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Could a natural hormone help tame a common heart rhythm disorder?
Disease control Not yet recruitingAtrial fibrillation (AF) is the most common heart rhythm disorder. The presence of AF increases the risk of death and is associated with a 5-6-fold increase in stroke incidence, due almost exclusively to thrombus formation in the heart. Current therapies for AF are limited. The e…
Phase: PHASE1, PHASE2 • Sponsor: Deeptankar DeMazumder • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Virtual reality rehab could ease chronic back pain without drugs
Symptom relief Not yet recruitingBackground Chronic musculoskeletal pain, especially chronic low back pain (CLBP), is the leading cause of disability worldwide, with a burden expected to rise due to aging and increased longevity. Despite strong evidence supporting multimodal and non-pharmacological management-pa…
Phase: NA • Sponsor: Universitat Jaume I • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC